| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $36.9M | +27.8% |
| Cost of Revenue | $28.6M | +117.4% |
| R&D Expense | $14.3M | +12.9% |
| SG&A Expense | $45.3M | -12.4% |
| Operating Income | -$55.5M | -14.3% |
| Interest Expense | $698K | -22.5% |
| Pre-tax Income | -$55.6M | -13.6% |
| Income Tax | $1.6M | +220.0% |
| Net Income | -$57.2M | -15.6% |
| EPS (Basic) | -$21.32 | -1770.2% |
| EPS (Diluted) | -$21.32 | -1770.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.4M | -74.0% |
| Short-term Investments | $16K | +0.0% |
| Accounts Receivable | $3.2M | -63.5% |
| Inventory | $9.7M | -33.3% |
| Current Assets | $31.1M | -61.2% |
| Total Assets | $31.8M | -60.7% |
| Current Liabilities | $27.6M | +23.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$36.7M | +38.4% |
| Investing Cash Flow | -$263K | -224.7% |
| Financing Cash Flow | $1.9M | -97.2% |
| Long-term Debt |
| $388K |
| -90.9% |
| Total Liabilities | $28.5M | +3.3% |
| Stockholders' Equity | $3.3M | -93.8% |